August 19, 2019
Rose
While Roche's decision to set its new cancer drug at such a different price level than its competitors sparked worries of a "pricing war in cancer," the nuances are more complicated.
from Kaiser Health News https://ift.tt/33G2p93
August 19, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Amid Surging Trend Of Hospital Mergers, Research Shows Quality Doesn’t Improve And Can Even Worsen- ‘Significant Safety Signal’: Encouraging Women To ‘Reverse’ Medical Abortions Endangers Their Health, Halted Study Reports
- ‘Sharing The Sentence’: Toll Taken On Millions Of American Children Mounts As More Mothers Are Incarcerated
- Desperate Americans Turn To Cost-Sharing Ministries, But There’s No Legal Guarantee Their Claims Will Be Covered
- State Highlights: Underfunded Alaskan Police Force Gets Life-Saving Support From Iowa Officer; New Yorkers Push Mayor About Street Safety After Cyclists’ Deaths
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment